| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 35 |
| 1 | BEVACIZUMAB | 22 |
| 2 | ASPIRIN | 16 |
| 3 | ASPIRIN 325 MG | 15 |
| 4 | ASPIRIN 81 MG | 15 |
| 5 | ATORVASTATIN CALCIUM | 15 |
| 6 | FINGOLIMOD HCL | 15 |
| 7 | LISINOPRIL | 14 |
| 8 | PIOGLITAZONE | 14 |
| 9 | AFLIBERCEPT | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TROPICAMIDE | 10 | 0.0061 |
| 1 | PROPARACAINE HYDROCHLORIDE | 2 | 0.0037 |
| 2 | POVIDONE-IODINE | 7 | 0.0016 |
| 3 | RANIBIZUMAB | 35 | 0.0013 |
| 4 | BESIFLOXACIN | 1 | 0.0010 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 6 | FARICIMAB | 4 | 0.0005 |
| 7 | AFLIBERCEPT | 12 | 0.0004 |
| 8 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 3 | 0.0004 |
| 9 | PIOGLITAZONE | 14 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 51 |
| 1 | Insulin Analog [EPC] | 31 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 17 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 16 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 6 | Anticholinergic [EPC] | 12 |
| 7 | Factor Xa Inhibitor [EPC] | 12 |
| 8 | Loop Diuretic [EPC] | 10 |
| 9 | Sulfonylurea [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 7 | 0.0016 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 4 | 0.0009 |
| 2 | Anticholinergic [EPC] | 12 | 0.0007 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Quinolone Antimicrobial [EPC] | 4 | 0.0004 |
| 5 | Radioactive Diagnostic Agent [EPC] | 1 | 0.0003 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 51 | 0.0003 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 9 | Allylamine Antifungal [EPC] | 1 | 0.0001 |